Tumor-derived GDF-15 suppresses immunotherapy response
Researchers evaluate the impact of tumor-derived GDF-15 on responses to anti-PD-1 immunotherapy.
Stay updated with breaking news from Programmed Cell Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers evaluate the impact of tumor-derived GDF-15 on responses to anti-PD-1 immunotherapy.
Talquetamab is the first therapy targeting GPRC5D to receive a positive CHMP Opinion Teclistamab, the first BCMA-targeting bispecific antibody to...
Lung cancer, one of the most aggressive forms of cancer, continues to be a leading cause of death worldwide. Although several new therapies have been developed for this disease, it has a poor prognosis in its advanced stages.
Researchers have for the first time characterized a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.
BEERSE, BELGIUM, June 03, 2023 (GLOBE NEWSWIRE) -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from...